Understanding the risk of diabetic retinopathy from glucagon-like peptide-1 receptor agonists: a Mendelian randomization study and systematic review of European populations.

GLP-1 受體促效劑對糖尿病視網膜病變風險的影響：歐洲族群的孟德爾隨機化研究與系統性回顧